Article Information
History
- January 28, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Salim Ilyasua,*,
- Sani Malamib,
- Garba Mohammed Khalidc,
- Umar Sharif Abdussalamb,
- Abubakar Magaji Dawudd,
- Saratu Mohammedd,
- Al-Kasim Rabiu Falalud,
- Mustapha Fatima Zaharadeend,
- Farouq Idris Sanid,
- Abdussalam Yayo Manue,
- Ibrahim Adamu Yakasaif,
- Basheer Abba-Zubair Chedib,
- Aminu Sahalu Belloe,
- Adam Bashir Ibrahima,
- Saadatu Juldeb,
- Maryam Shehu Idrisg and
- Lawal Alhassan Bichib
- aDepartment of Pharmaceutics and Pharmaceutical Technology, Bayero University, Kano, Nigeria
- bDepartment of Pharmacology and Therapeutics, Bayero University, Kano, Nigeria
- cDepartment of Pharmaceutics, University College London, London, United Kingdom
- dFaculty of Pharmaceutical Sciences, Bayero University, Kano
- eDepartment of Medical Microbiology and Parasitology, Bayero University, PMB 3011, Kano, Nigeria
- fDepartment of Pharmaceutical and Medicinal Chemistry, Bayero University, PMB 3011, Kano, Nigeria
- gSchool of Environmental and Life Sciences, University of Salford, United Kingdom
- ↵*Corresponding author Email: silyasu.pht{at}buk.edu.ng
Posted January 28, 2024.
Application of hybrid failure mode effect analysis based on fuzzy AHP and fuzzy TOPSIS in quality risk assessment of fixed-dose artemether-lumefantrine tablets
